Covidien wins FDA nod for oximeter; Study: Biotronik's stent equals Abbott's;

 @FierceMedDev: Roche launches DNA kit amid applied science shake-up. Article | Follow @FierceMedDev

 @DamianFierce: In case you missed it Monday, Valeant is buying Bausch + Lomb for $8.7B. Report | Follow @DamianFierce

> Covidien ($COV) won an expanded FDA clearance for its Nellcor Pulse Oximeter, now labeled for use in newborn screening for congenital heart disease. News

> Biotronik's Osiro stent proved just as effective as Abbott Laboratories' ($ABT) Xience Prime in patients with coronary lesions, according to a study. Article

> California startup Scanadu is developing a diagnostic device modeled after the famed tricorder from "Star Trek," and the company has more than tripled its initial fundraising goal on Indiegogo. Story

> At the American Society of Clinical Oncology's annual meeting, Clearbridge BioMedics unveiled its ClearCell FX system, designed for use in in vitro cancer diagnostics. Item

> Devicemaker iTraumaCare won FDA clearance for the iTClamp, a bleeding-control system for use in treating traumatic injury. More

> Diagnostics company Tethys Bioscience has launched a finger-stick application of its PreDx test, used to stratify and monitor prediabetes patients. Release

Biotech News

 @FierceBiotech: Trending this weekend: Top 10 Biotech CEO Pay Packages of 2012. Feature | Follow @FierceBiotech

 @JohnCFierce: From earlier today: AstraZeneca scoops up PhIII cardio drug in $443M Omthera buyout (did AZ pay too much?) Story | Follow @JohnCFierce

> Are biotech IPOs already getting too hot to handle? More

> Biotech gets $12M to work on amped-up herbal anti-inflammatory. Item

> Pharmaxis slashes staff after FDA red-flags cystic fibrosis treatment. Article

> Alexion snags latest 'breakthrough' coup with PhIII rare-disease drug. News

Pharma News

 @FiercePharma: India's Sun Pharma beats on profits, with 31% revenue hike to about $550M. More | Follow @FiercePharma

 @EricPFierce: U.S. arrests 2 Pakistani men for selling controlled substances via the Internet. Interpol tracks them to London. Report | Follow @EricPFierce

> Feds subpoena Forest Labs in Tudorza Pressair investigation. Story

> Drugmakers to reap $115B in sales as Obamacare rolls on, study finds. Report

> ISTA excluded from Medicare in $33.5M off-label settlement. Article

Pharma Manufacturing News

> India takes another step to meet looming EU API rules. Story

> FDA tracking down new outbreak tied to compounded drug. More

> U.S. holds two Pakistani men for Internet sales of controlled substances. Report

> Indian regulators unsure how to react to USFDA actions. Article

CRO News

> Parexel expands eClinical presence in China. Article

> India amps up clinical trial consent regulations. Report

> Corgenix inks cancer deal with Lilly. More

> Nordion sells off drug unit for $200M, focuses on contracting. Story

Biotech IT News

> Boehringer VP impressed by wireless pill bottle. Item

> Treato sees success for Biogen in social media buzz. Article

> Genentech asks iPad gamers to save San Fran from mutant cheese. More

> Chinese trial data hackers reportedly active again. Report

Biotech Research News

 @EmilyMFierce: Universal flu vaccine effective in preclinical studies. More | Follow @EmilyMFierce

> Stem cell cloning study contained errors. Story

> Stabilizing a gene reverses schizophrenia in mice. Report

> New study refutes Targretin claim for treatment of Alzheimer's. Article

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.